Glycated albumin levels in the third trimester of women with gestational diabetes mellitus are associated with adverse pregnancy-related outcomes

Abstract Background Glycated albumin (GA) levels have been considered as a promising biomarker for estimating glycemic control during pregnancy, but the relationship between GA levels and the incidence of adverse pregnancy outcomes in women with gestational diabetes mellitus (GDM) remains unclear. O...

Full description

Saved in:
Bibliographic Details
Main Authors: Yueshuai Pan, Ruting Gu, Qianqian Li, Jingyuan Wang, Yan Zhang, Lin Zhao, Yue Wu, Lili Wei
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Pregnancy and Childbirth
Subjects:
Online Access:https://doi.org/10.1186/s12884-024-06994-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846158154439589888
author Yueshuai Pan
Ruting Gu
Qianqian Li
Jingyuan Wang
Yan Zhang
Lin Zhao
Yue Wu
Lili Wei
author_facet Yueshuai Pan
Ruting Gu
Qianqian Li
Jingyuan Wang
Yan Zhang
Lin Zhao
Yue Wu
Lili Wei
author_sort Yueshuai Pan
collection DOAJ
description Abstract Background Glycated albumin (GA) levels have been considered as a promising biomarker for estimating glycemic control during pregnancy, but the relationship between GA levels and the incidence of adverse pregnancy outcomes in women with gestational diabetes mellitus (GDM) remains unclear. Our study aimed to investigate the relationship between GA levels during the third trimester and 13 different adverse pregnancy-related outcomes among women with GDM in China. Methods We retrospectively extracted clinical data from the medical records of 819 pregnant women with GDM who underwent prenatal examinations and child delivery at the Affiliated Hospital of Qingdao University between January 2022 and October 2022. The cohort was divided into GA-high (GA-H) and GA-low (GA-L) groups based on the median GA level of 10.6%. Then, the incidence rates of 13 specific adverse pregnancy outcomes were compared between the two groups. Furthermore, we estimated the mean GA levels in pregnant GDM women with or without specific adverse outcomes. Multivariate logistic regression analysis was performed to assess whether the GA levels (high or low) were independent risk factors for specific adverse outcomes in pregnant women with GDM. Receiver operating characteristic (ROC) curve analysis was performed to assess the predictive value of GA levels for the adverse pregnant outcomes in women with GDM. E-value for sensitivity analysis was performed to assess the robustness of the findings to unmeasured confoundings. Results We included 819 pregnant women with GDM, whose average age was 33.09 ± 4.47 years, average pre-pregnancy BMI was 23.51 ± 3.67 kg/m2, and the average gestational week in which GDM diagnosed was 24.80 ± 1.79 weeks. The analysis showed that 80.71% (661/819) pregnant women with GDM were associated with adverse pregnancy-related outcomes. Pregnant women in the GA-L group showed higher incidence of the premature rupture of membranes (PROM), whereas those in the GA-H group showed higher incidence of neonatal hypoglycemia. The GA levels showed acceptable clinical performance for predicting neonatal hypoglycemia with an area under the ROC curve (AUC) value of 0.700 (P = 0.010), sensitivity of 71.4%, and specificity of 70.2%. The optimal cut off value for GA was 11.55%. Conclusions This study demonstrated that GA levels were significantly associated with specific adverse pregnancy outcomes, especially PROM and neonatal hypoglycemia. Furthermore, GA levels in the third trimester showed acceptable clinical performance for predicting neonatal hypoglycemia among pregnant women with GDM. In the future, the potential role of GA as a predictor of adverse pregnancy outcomes need to be further confirmed and explored in GDM women.
format Article
id doaj-art-29954f28ee0c48ad929cc3821557b6e8
institution Kabale University
issn 1471-2393
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series BMC Pregnancy and Childbirth
spelling doaj-art-29954f28ee0c48ad929cc3821557b6e82024-11-24T12:47:13ZengBMCBMC Pregnancy and Childbirth1471-23932024-11-012411910.1186/s12884-024-06994-yGlycated albumin levels in the third trimester of women with gestational diabetes mellitus are associated with adverse pregnancy-related outcomesYueshuai Pan0Ruting Gu1Qianqian Li2Jingyuan Wang3Yan Zhang4Lin Zhao5Yue Wu6Lili Wei7Department of Nursing, The Affiliated Hospital of Qingdao UniversityDepartment of Thoracic Surgery, The Affiliated Hospital of Qingdao UniversityOphthalmology Department, The Affiliated Hospital of Qingdao UniversityDepartment of Neurology, The Affiliated Hospital of Qingdao UniversityDepartment of Nursing, The Affiliated Hospital of Qingdao UniversityDepartment of Nursing, The Affiliated Hospital of Qingdao UniversityDepartment of Nursing, The Affiliated Hospital of Qingdao UniversityOffice of the Dean, The Affiliated Hospital of Oingdao UniversityAbstract Background Glycated albumin (GA) levels have been considered as a promising biomarker for estimating glycemic control during pregnancy, but the relationship between GA levels and the incidence of adverse pregnancy outcomes in women with gestational diabetes mellitus (GDM) remains unclear. Our study aimed to investigate the relationship between GA levels during the third trimester and 13 different adverse pregnancy-related outcomes among women with GDM in China. Methods We retrospectively extracted clinical data from the medical records of 819 pregnant women with GDM who underwent prenatal examinations and child delivery at the Affiliated Hospital of Qingdao University between January 2022 and October 2022. The cohort was divided into GA-high (GA-H) and GA-low (GA-L) groups based on the median GA level of 10.6%. Then, the incidence rates of 13 specific adverse pregnancy outcomes were compared between the two groups. Furthermore, we estimated the mean GA levels in pregnant GDM women with or without specific adverse outcomes. Multivariate logistic regression analysis was performed to assess whether the GA levels (high or low) were independent risk factors for specific adverse outcomes in pregnant women with GDM. Receiver operating characteristic (ROC) curve analysis was performed to assess the predictive value of GA levels for the adverse pregnant outcomes in women with GDM. E-value for sensitivity analysis was performed to assess the robustness of the findings to unmeasured confoundings. Results We included 819 pregnant women with GDM, whose average age was 33.09 ± 4.47 years, average pre-pregnancy BMI was 23.51 ± 3.67 kg/m2, and the average gestational week in which GDM diagnosed was 24.80 ± 1.79 weeks. The analysis showed that 80.71% (661/819) pregnant women with GDM were associated with adverse pregnancy-related outcomes. Pregnant women in the GA-L group showed higher incidence of the premature rupture of membranes (PROM), whereas those in the GA-H group showed higher incidence of neonatal hypoglycemia. The GA levels showed acceptable clinical performance for predicting neonatal hypoglycemia with an area under the ROC curve (AUC) value of 0.700 (P = 0.010), sensitivity of 71.4%, and specificity of 70.2%. The optimal cut off value for GA was 11.55%. Conclusions This study demonstrated that GA levels were significantly associated with specific adverse pregnancy outcomes, especially PROM and neonatal hypoglycemia. Furthermore, GA levels in the third trimester showed acceptable clinical performance for predicting neonatal hypoglycemia among pregnant women with GDM. In the future, the potential role of GA as a predictor of adverse pregnancy outcomes need to be further confirmed and explored in GDM women.https://doi.org/10.1186/s12884-024-06994-yGestational diabetes mellitusGlycated albuminAdverse pregnancy outcomesPremature rupture of membranesNeonatal hypoglycemia
spellingShingle Yueshuai Pan
Ruting Gu
Qianqian Li
Jingyuan Wang
Yan Zhang
Lin Zhao
Yue Wu
Lili Wei
Glycated albumin levels in the third trimester of women with gestational diabetes mellitus are associated with adverse pregnancy-related outcomes
BMC Pregnancy and Childbirth
Gestational diabetes mellitus
Glycated albumin
Adverse pregnancy outcomes
Premature rupture of membranes
Neonatal hypoglycemia
title Glycated albumin levels in the third trimester of women with gestational diabetes mellitus are associated with adverse pregnancy-related outcomes
title_full Glycated albumin levels in the third trimester of women with gestational diabetes mellitus are associated with adverse pregnancy-related outcomes
title_fullStr Glycated albumin levels in the third trimester of women with gestational diabetes mellitus are associated with adverse pregnancy-related outcomes
title_full_unstemmed Glycated albumin levels in the third trimester of women with gestational diabetes mellitus are associated with adverse pregnancy-related outcomes
title_short Glycated albumin levels in the third trimester of women with gestational diabetes mellitus are associated with adverse pregnancy-related outcomes
title_sort glycated albumin levels in the third trimester of women with gestational diabetes mellitus are associated with adverse pregnancy related outcomes
topic Gestational diabetes mellitus
Glycated albumin
Adverse pregnancy outcomes
Premature rupture of membranes
Neonatal hypoglycemia
url https://doi.org/10.1186/s12884-024-06994-y
work_keys_str_mv AT yueshuaipan glycatedalbuminlevelsinthethirdtrimesterofwomenwithgestationaldiabetesmellitusareassociatedwithadversepregnancyrelatedoutcomes
AT rutinggu glycatedalbuminlevelsinthethirdtrimesterofwomenwithgestationaldiabetesmellitusareassociatedwithadversepregnancyrelatedoutcomes
AT qianqianli glycatedalbuminlevelsinthethirdtrimesterofwomenwithgestationaldiabetesmellitusareassociatedwithadversepregnancyrelatedoutcomes
AT jingyuanwang glycatedalbuminlevelsinthethirdtrimesterofwomenwithgestationaldiabetesmellitusareassociatedwithadversepregnancyrelatedoutcomes
AT yanzhang glycatedalbuminlevelsinthethirdtrimesterofwomenwithgestationaldiabetesmellitusareassociatedwithadversepregnancyrelatedoutcomes
AT linzhao glycatedalbuminlevelsinthethirdtrimesterofwomenwithgestationaldiabetesmellitusareassociatedwithadversepregnancyrelatedoutcomes
AT yuewu glycatedalbuminlevelsinthethirdtrimesterofwomenwithgestationaldiabetesmellitusareassociatedwithadversepregnancyrelatedoutcomes
AT liliwei glycatedalbuminlevelsinthethirdtrimesterofwomenwithgestationaldiabetesmellitusareassociatedwithadversepregnancyrelatedoutcomes